Editas Medicine announces 3-year research collaboration with the SR-TIGET

GEN News Highlights, 28 July 2016, http://www.genengnews.com/gen-news-highlights/editas-sr-tiget-launch-research-collaboration/81253014/

Editas and the San Raffaele Telethon Institute for Gene Therapy (SR-TIGET) have agreed to a 3-year research collaboration to study genome-edited hematopoietic stem cells and T-cell therapies.  This collaboration could work to advance Editas’ CRISPR based treatments for blood and bone marrow disorders and the engineering of T-cells to fight cancer.  The value of this arrangement was not disclosed.

Author: Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare.

Leave a Reply